Endogenous cannabinoid ligands

Advances in Experimental Medicine and Biology

Volumn 402, Issue , 1996, Pages 95-100

  Mechoulam, R ^a   Ben Shabat, S ^a   Hanus L ^a   Fride, E ^a   Bayewitch, M ^b   Vogel, Z ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DELTA8 TETRAHYDROCANNABINOL; DEXANABINOL; DRONABINOL; ETHANOLAMINE DERIVATIVE; HU 243; LIGAND; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOSPECIFICITY;

EID: 10144253122     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0407-4_14     Document Type: Conference Paper

References (30)

1. R. Mechoulam, The Pharmacohistory of Cannabis sativa, in "Cannabinoids as Therapeutic Agents", R. Mechoulam, Ed., CRC Press, 1986, pp. 1-20.
2. Y. Gaoni and R. Mechoulam, Isolation, structure and partial synthesis of an active constituent of hashish, J. Amer. Chem. Soc. 86:1646 (1964).
3. R. Mechoulam, N.K. McCallum and S. Burstein, Recent advances in the chemistry and biochemistry of cannabis, Chem. Revs. 76:75 (1976).
4. B.R. Martin, Cellular effects of cannabinoids, Pharmacol. Revs. 38:45 (1986).
5. R. Mechoulam, W.A. Devane, R. Glaser, Cannabinoid geometry and biological activity, in "Marijuana/Cannabinoids: Neurobiology and Neurophysiology", ed. L. Murphy and A. Bartke. CRC Press, Boca Raton, FL. 1992. pp. 1-33.
6. W.A. Devane, F.A. Dysarz, III, M.R. Johnson, S.L. Melvin and A.C. Howlett, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol. 34:605 (1988).
7. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young and T.I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346:561 (1990).
8. W.A. Devane, A. Breuer, T. Sheskin, T.U.C. Järbe, M. Eisen and R. Mechoulam, A novel probe for the cannabinoid receptor, J. Med. Chem. 35:2065 (1992).
9. W.A. Devane, L. Hanuš, A. Breuer, R.G. Pertwee, L.A. Stevenson. G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger and R. Mechoulam, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258:1946 (1992).
10. E. Fride and R. Mechoulam, Pharmacological activity of the cannabinoid agonist anandamide, a brain constituent, Eur. J. Pharmacol. 231:313 (1993).
11. P.B. Smith, D.R. Compton, S.P. Welch, R.K. Razdan, R. Mechoulam and B.R. Martin, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice, J. Pharmacol. Exp. Ther. 270:219 (1994).
12. L. Hanuš, A. Gopher, S. Almog and R. Mechoulam, Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor, J. Med. Chem. 36:3032 (1993).
13. D.G. Deutsch and S.A. Chin, Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist, Biochem. Pharmacol. 46:791 (1993).
14. Z. Vogel, J. Barg, R. Levy, D. Saya, E. Heldman and R. Mechoulam, Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase, J. Neurochem. 61:352 (1993).
15. J. Weidenfeld, S. Feldman and R. Mechoulam, The effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat, Neuroendocrin. 59:110 (1994).
16. A. Abrahamov, A. Abrahamov and R. Mechoulam. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sciences 56:2097 (1995).
17. E. Fride and R. Mechoulam, Developmental aspects of anandamide: Ontogeny of response and effects of prenatal exposure to anandamide, Psychoneuroendocrin. (in press).
18. S. Munro, K.L. Thomas and M. Abu-Shaar, Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61 (1993).
19. R. Mechoulam, S. Ben-Shabat, L. Hanuš, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton, R.G. Pertwee, G. Griffin, M. Bayewitch, J. Barg and Z. Vogel, Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol 50:83 (1995).
20. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa and K.C. Rice, Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. USA, 87:1932 (1990).
21. T.W.Klein, C. Newton, W.G. Zhu, Y. Daaka and H. Friedman, Delta-9-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Proc. Soc. Exper. Biol. Med. 209:205 (1995).
22. K.L. McCoy, D. Gainey and G.A. Cabrai, Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273:1216 (1995).
23. H. Friedman, S. Specter and T.W.Klein (eds) in Drugs of Abuse, Immunity and Immunodeficiency. Plenum Press, New York (1991).
24. J.L. Tang, G. Lancz and S. Specter, Delta-9-tetrahydrocannabinol (THC) mediated inhibition of macrophage macromolecular metabolism is antagonized by human serum proteins and by cell surface proteins. Int. J. Immunopharmacol. 15:665 (1993).
25. N. Titishov, R. Mechoulam and A.M. Zimmerman. Stereospecific effects of (-) and (+)-7-hydroxy-delta-6-tetrahyrocannabinol-dimethyl-heptyl on the immune system of mice. Pharmacol. 39:337 (1989).
26. L. Facci, R. Dal-Toso, S. Romanello, A. Buriani, S.D. Skaper and A. Leon, Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA. 92:3376 (1995).
27. M. Lee, K. Hwan Yang and N.E. Kaminski, Effects of putative cannabinoid receptor ligands, anandamide and 2-Arachidonyl-Glycerol, on immune function in B6C3F1 mouse splenocytes, J. Pharmacol. & Experim. Ther. 275:529 (1995).
28. H. Schwarz, F.J. Blanco and M. Lotz, Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis, J. Neuroimmunol. 55:107 (1994).
29. H. Schuel, E. Goldstein, R. Mechoulam, A.M. Zimmerman and S. Zimmerman, Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction, Proc. Natl. Acad. Sci. USA. 91:7678 (1994).
30. S. Dalterio, F. Badr, A. Bartke and D. Mayfield, Cannabinoids in male mice: effects of fertility and spermatogenesis, Science 216:315 (1982).